Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIC: Individualized vs Standard Care for CINV in Breast Cancer
NCT01913990Phase 4Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Sep 2011
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, ondansetron, aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
dexamethasoneondansetronaprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01913990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913990.